Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620733
Title:
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
Authors:
Azizi, M. [et al]; Sharp, Andrew
Abstract:
Early studies suggest that radiofrequency-based renal denervation reduces blood pressure in patients with moderate hypertension. We investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications.
Citation:
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. 2018, 391 (10137):2335-2345 Lancet
Publisher:
Elsevier
Journal:
Lancet (London, England)
Issue Date:
9-Jun-2018
URI:
http://hdl.handle.net/11287/620733
DOI:
10.1016/S0140-6736(18)31082-1
PubMed ID:
29803590
Additional Links:
https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(18)31082-1
Type:
Journal Article
Language:
en
ISSN:
1474-547X
Appears in Collections:
Cardiology; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorAzizi, M. [et al]en
dc.contributor.authorSharp, Andrewen
dc.date.accessioned2018-06-29T14:16:42Z-
dc.date.available2018-06-29T14:16:42Z-
dc.date.issued2018-06-09-
dc.identifier.citationEndovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. 2018, 391 (10137):2335-2345 Lanceten
dc.identifier.issn1474-547X-
dc.identifier.pmid29803590-
dc.identifier.doi10.1016/S0140-6736(18)31082-1-
dc.identifier.urihttp://hdl.handle.net/11287/620733-
dc.description.abstractEarly studies suggest that radiofrequency-based renal denervation reduces blood pressure in patients with moderate hypertension. We investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications.en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0140-6736(18)31082-1en
dc.rightsArchived with thanks to Lancet (London, England)en
dc.subjectWessex Classification Subject Headings::Cardiologyen
dc.titleEndovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.en
dc.typeJournal Articleen
dc.identifier.journalLancet (London, England)en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.